Alessandro Gulino
- Immunology top 10%
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Oncology top 10%
- Genetics top 10%
- Mesenchymal stem cell research 5
- Chronic Lymphocytic Leukemia Research 3
- Hematology top 10%
-
- Lymphoma Diagnosis and Treatment 5
-
- Asthma and respiratory diseases 4
- Co-authors
- Claudio TripodoBeatrice BelmonteMario P. ColomboSabina SangalettiMelchiorre CervelloGiuseppe MontaltoPaola PortararoLaura Botti
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Alessandro Gulino
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Immunology 425
- Oncology 288
- Genetics 109
- Cancer Research 151
- Hematology 110
Countries citing papers authored by Alessandro Gulino
This map shows the geographic impact of Alessandro Gulino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Gulino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Gulino more than expected).
Fields of papers citing papers by Alessandro Gulino
This network shows the impact of papers produced by Alessandro Gulino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Gulino. The network helps show where Alessandro Gulino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandro Gulino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 35 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 15 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 23 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 18 | |
| 10 | 2018 | 23 | |
| 11 | 2018 | 21 | |
| 12 | 2017 | 28 | |
| 13 | 2017 | 63 | |
| 14 | 2017 | 13 | |
| 15 | 2017 | 16 | |
| 16 | 2016 | 92 | |
| 17 | 2015 | 16 | |
| 18 | 2014 | 68 | |
| 19 | 2014 | 15 | |
| 20 | Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer. | 1997 | 3 |
About Alessandro Gulino
Alessandro Gulino is a scholar working on Genetics, Immunology, Hematology, Rheumatology and Pathology and Forensic Medicine, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (5 papers), Mesenchymal stem cell research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Immune cells in cancer (4 papers), Asthma and respiratory diseases (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Immunology (425 citations), Oncology (288 citations), Genetics (109 citations), Cancer Research (151 citations) and Hematology (110 citations). Alessandro Gulino has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Claudio Tripodo, Beatrice Belmonte, Mario P. Colombo, Sabina Sangaletti, Melchiorre Cervello, Giuseppe Montalto, Paola Portararo, Laura Botti, Fabio Salvatore Palumbo and Giovanna Pitarresi. Their work appears in journals such as Frontiers in Immunology, Blood, OncoImmunology, British Journal of Haematology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.